论文部分内容阅读
目的观察奥扎格雷钠联合降栓酶用于脑血栓治疗的临床效果。方法选取医院收治的脑血栓患者94例作为研究对象,随机分为观察组和对照组,每组47例。对照组单纯给予奥扎格雷钠治疗,观察组给予奥扎格雷钠与降栓酶联合治疗,观察2组患者的临床疗效和血脂指标水平变化。结果观察组总有效率为95.7%,高于对照组的74.5%(P<0.05)。2组患者血脂指标水平比较,差异均有统计学意义(P<0.05)。结论脑血栓患者采用奥扎格雷钠与降栓酶联合治疗,可显著提高治疗效率,改善血脂指标水平,是一种值得临床选用与普及的治疗方法。
Objective To observe the clinical effect of ozagrel combined with desmopressin in the treatment of cerebral thrombosis. Methods Ninety-four patients with cerebral thrombosis admitted to hospital were selected as study subjects and randomly divided into observation group and control group, with 47 cases in each group. The control group was treated with ozagrel sodium alone. The observation group was given sodium ozagrel and thromboxanin combined therapy. The clinical efficacy and the level of serum lipids were observed in the two groups. Results The total effective rate in observation group was 95.7%, which was higher than 74.5% in control group (P <0.05). The levels of serum lipids in the two groups were significantly different (P <0.05). Conclusion Cerebral thrombosis patients treated with sodium ozagrel and thromboxanin can significantly improve the therapeutic efficiency and improve the level of serum lipids, which is a clinically appropriate and popular treatment.